Merit Financial Group, LLC Boston Scientific Corp Transaction History

Merit Financial Group, LLC

$4.59 Billion
Q3 2024

A detailed history of Merit Financial Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Merit Financial Group, LLC holds 95,980 shares of BSX stock, worth $8.68 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

95,980

Previous 105,619 9.13%

Holding current value

$8.68 Million

Previous $8.13 Million 1.11%

% of portfolio

0.18%

Previous 0.17%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$72.96 - $84.0 $703,261 - $809,676	-9,639 Reduced 9.13%	95,980 $8.04 Million
Q2 2024 Aug 13, 2024	BUY	$67.33 - $77.71 $283,055 - $326,692	4,204 Added 4.15%	105,619 $8.13 Million
Q1 2024 May 06, 2024	BUY	$57.6 - $68.62 $526,521 - $627,255	9,141 Added 9.91%	101,415 $6.95 Million
Q4 2023 Feb 06, 2024	BUY	$48.64 - $57.81 $348,359 - $414,035	7,162 Added 8.41%	92,274 $5.33 Million
Q3 2023 Nov 07, 2023	SELL	$50.19 - $54.68 $513,142 - $559,048	-10,224 Reduced 10.72%	85,112 $4.49 Million
Q2 2023 Aug 01, 2023	BUY	$49.72 - $54.64 $130,763 - $143,703	2,630 Added 2.84%	95,336 $5.16 Million
Q1 2023 Apr 24, 2023	BUY	$45.09 - $50.03 $94,508 - $104,862	2,096 Added 2.31%	92,706 $4.64 Million
Q4 2022 Jan 13, 2023	BUY	$39.56 - $47.22 $741,552 - $885,138	18,745 Added 26.08%	90,610 $0
Q3 2022 Oct 31, 2022	BUY	$36.71 - $109.66 $2.64 Million - $7.88 Million	71,865 New	71,865 $2.78 Million
Q1 2020 May 05, 2020	SELL	$25.83 - $45.71 $135,943 - $240,571	-5,263 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$37.87 - $45.37 $199,309 - $238,782	5,263 New	5,263 $238,000

Others Institutions Holding BSX

# of Institutions

1,543

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $130B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.

Account

Merit Financial Group, LLC Boston Scientific Corp Transaction History